Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Osteoporosis International
Erschienen in: Osteoporosis International 5/2013

01.05.2013 | Review

How important is vitamin D in preventing infections?

verfasst von: P. O. Lang, N. Samaras, D. Samaras, R. Aspinall

Erschienen in: Osteoporosis International | Ausgabe 5/2013

Einloggen, um Zugang zu erhalten

Abstract

Interaction with the immune system is one of the most recently established nonclassic effects of vitamin D (VitD). For many years, this was considered to be limited to granulomatous diseases in which synthesis of active 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) or calcitriol is known to be increased. However, recent reports have supported a role for 1,25(OH)2D3 in promoting normal function of the innate and adaptive immune systems. Crucially, these effects seem to be mediated not only by the endocrine function of circulating calcitriol but also via paracrine (i.e., refers to effects to adjacent or nearby cells) and/or intracrine activity (i.e., refers to a hormone acting inside a cell) of 1,25(OH)2D3 from its precursor 25(OH)D3, the main circulating metabolite of VitD. The ability of this vitamin to influence human immune responsiveness seems to be highly dependent on the 25(OH)D3 status of individuals and may lead to aberrant response to infection or even to autoimmunity in those who are lacking VitD. The potential health significance of this has been underlined by increasing awareness of impaired status in populations across the globe. This review will examine the current understanding of how VitD status may modulate the responsiveness of the human immune system. Furthermore, we discuss how it may play a role in host resistance to common pathogens and how effective is its supplementation for treatment or prevention of infectious diseases in humans.
Literatur
1.
2.
Hewison M (2012) An update on vitamin D and human immunity. Clin Endocrinol 76:315–325CrossRef
3.
Di Rosa M, Malaguarnera M, Nicoletti F, Malaguarnera L (2011) Vitamin D3: a helpful immuno-modulator. Immunology 134:123–139PubMedCrossRef
4.
Van Belle TL, Gysemans C, Mathieu C (2011) Vitamin D in autoimmune, infectious and allergic diseases: a vital player? Best Pract Res Clin Endocrinol Metab 25:617–632PubMedCrossRef
5.
Khoo LA, Chai L, Koenen H, Joosten I, Netea M, van der Ven A (2012) Translating the role of vitamin D3 in infectious diseases. Crit Rev Microbiol 38:122–135PubMedCrossRef
6.
7.
Lang PO, Mitchell WA, Lapenna A, Pitts D, Aspinall R (2010) Immunological pathogenesis of main aged-related disease and frailty: role of immunosenescence. Eur Geriatr Med 1:112–121CrossRef
8.
Bischoff-Ferrari HA, Dawson-Hughes B, Platz A, Orav EJ, Stähelin HB, Willett WC, Can U, Egli A, Mueller NJ, Looser S, Bretscher B, Minder E, Vergopoulos A, Theiler R (2010) Effect of high-dosage cholecalciferol and extended physiotherapy on complications after hip fracture: a randomized controlled trial. Arch Intern Med 170:813–820PubMedCrossRef
9.
Hart PH, Gorman S, Finlay-Jones JJ (2011) Modulation of the immune system by UV radiation: more than just the effects of vitamin D? Nat Rev Immunol 11:584–596PubMedCrossRef
10.
Mann T (1924) The magic mountain (Der Zauberberg). S. Fisher Verlag, Berlin
11.
Chesney RW (2010) Vitamin D and the magic mountain: the anti-infectious role of the vitamin D. J Pediatr 156:698–703PubMedCrossRef
12.
Tan SY, Lindsey K (2011) Medicine in stamps: Niels Finsen (1860–1904): gift of light. Singapore Med J 52:778
13.
14.
Bryder L (1987) Below the magic mountain—a social history of tuberculosis in twentieth century Britain, vol. 7. Clarendon Press, Oxford
15.
16.
Sugiura M, Nakamura M, Ogawa K, Ikoma Y, Ando F, Shimokata H, Yano M (2011) Dietary patterns of antioxidant vitamin and carotenoid intake associated with bone mineral density: findings from post-menopausal Japanese female subjects. Osteoporos Int 22:143–152PubMedCrossRef
17.
Van Etten E, Mathieu C (2005) Immunoregulation by 1,25-di-hydroxy1,25(OH)2D3: basic concepts. J Steroid Biochem Mol Biol 97:93–101PubMedCrossRef
18.
Papapoulos SE, Clemens TL, Fraher LJ, Lewin IG, Sandler LM, O’Riordan JL (1979) 1,25 di-hydroxycholecalciferol in the pathogenesis of the hypercalcemia of sarcoidosis. Lancet 1:627–630PubMedCrossRef
19.
Hewison M (2012) Vitamin D and immune function: autocrine, paracrine or endocrine? Scand J Clin Lab Invest Suppl 243:92–102PubMed
20.
White JH (2012) Vitamin D metabolism and signaling in the immune system. Rev Endocr Metab Disord 13:21–29PubMedCrossRef
21.
22.
Chen S, Sims GP, Chen XX, Gu YY, Chen S, Lipsky PE (2007) Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol 179:1634–1647PubMed
23.
Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, Ochoa MT, Schauber J, Wu K, Meinken C, Kamen DL, Wagner M, Bals R, Steinmeyer A, Zugel U, Gallo RL, Eisenberg D, Hewison M, Hollis BW, Adams JS, Bloom BR, Modlin RL (2006) Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311:1770–1773PubMedCrossRef
24.
Hewison M (2010) Vitamin D and the immune system: new perspectives on an old theme. Endocrinol Metab Clin N Am 39:365–379CrossRef
25.
Yamshchikov AV, Desai NS, Blumberg HM, Ziegler TR, Tangpricha V (2009) Vitamin D for treatment and prevention of infectious diseases: a systemic review of randomized controlled trials. Endocr Pract 15:438–449PubMedCrossRef
26.
Dempsey PW, Vaidya SA, Cheng G (2003) The art of war: innate and adaptive immune responses. Cell Mol Life Sci 60:2604–2621PubMedCrossRef
27.
28.
Andorini L, Penna G, Giarratana N, Roncari A, Amuchastegui S, Daniel KC, Uskokovic M (2004) Dendritic cells as key target for immunomodulation by vitamin D receptor ligands. J Steroid Biochem Mol Biol 90:437–441CrossRef
29.
Liu YJ (2005) IPC: professional type I interferon-producing cells and plasmacytoid dendritic cell precursor. Annu Rev Immunol 23:275–306PubMedCrossRef
30.
Steinman RM, Hawiger D, Nussenzweig MC (2003) Tolerogenic dendritic cells. Annu Rev Immunol 21:685–711PubMedCrossRef
31.
Abdelsadik A, Trad A (2011) Toll-like receptors on the fork roads between innate and adaptive immunity. Hum Immunol 72:1188–1193PubMedCrossRef
32.
Rodríguez RM, López-Vázquez A, López-Larrea C (2012) Immune systems evolution. Adv Exp Med Biol 739:237–251PubMedCrossRef
33.
Abbas AK, Murphy KM, Sher A (1996) Functional diversity of helper T lymphocytes. Nature 383:1357–1366CrossRef
34.
35.
Peck A, Mellins ED (2010) Precarious balance: Th17 cells in host defense. Infect Immun 78:32–38PubMedCrossRef
36.
Korn T, Oukka M, Kuchroo V, Betteli E (2007) Th17 cells: effector cells with inflammatory properties. Semin Immunol 19:362–371PubMedCrossRef
37.
Tang J, Zhou R, Luger D et al (2009) Calcitriol suppresses antiretinal autoimmunity through inhibitory effects on the Th-17 effector response. J Immunol 167:4974–4980
38.
Penna G, Adorini L (2000) 1 alpha,25-dihydroxyvitamin D-3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol 164:2405–2411PubMed
39.
Jeffery LE, Burke F, Mura M et al (2009) 1,25-dihydroxyvitamin D(3) and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. J Immunol 183:5458–5467PubMedCrossRef
40.
Eyerich S, Eyerich K, Pennino D, Carbone T, Nasorri F, Pallotta S, Cianfarani F, Odorisio T, Traidl-Hoffmann C, Behrendt H, Durham SR, Schmidt-Weber CB, Cavani A (2009) Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. J Clin Invest 119:3573–3585PubMed
41.
Ma CS, Tangye SG, Deenick EK (2010) Human Th9 cells: inflammatory cytokines modulate IL-9 production through the induction of IL-21. Immunol Cell Biol 88:621–623PubMedCrossRef
42.
Braciale TJ, Sun J, Kim TS (2012) Regulating the adaptive immune response to respiratory virus infection. Nat Rev Immunol 12:295–305PubMedCrossRef
43.
Carlberg C, Seuter S, Heikkinen S (2012) The first gemone-wide view of vitamin D receptor locations and their mechanistic implications. Anticancer Res 32:271–282PubMed
44.
Moore DD, Kato S, Xie W, Mangelsdorf DJ, Schmidt DR, Xiao R, Kliewer SA (2006) International Union of Pharmacology. LXII. The NR1H and NR1I receptors: constitutive androstane receptor, pregnene X receptor, farnesoid X receptor alpha, farnesoid X receptor beta, liver X receptor alpha, liver X receptor beta, and vitamin D receptor. Pharmacol Rev 58:742–759. doi:710.​1124/​pr.​1158.​1124.​1126 PubMedCrossRef
45.
Chawla A, Repa J, Evans RM, Mangelsdorf DJ (2001) Nuclear receptors and lipid physiology: opening hte X-files. Science 294:1866–1870PubMedCrossRef
46.
Carlberg C, Polly P (1998) Gene regulation by 1,25(OH)2D3. Crit Rev Eukariot Gene Expr 8:19–42CrossRef
47.
Aranda A, Pascual A (2001) Nuclear hormon receptors and gene expression. Physiol Rev 81:1269–1304PubMed
48.
Wang Y, Zhu J, DeLuca HF (2012) Where is the vitamin D receptor? Arch Biochem Biophys 523:123–133PubMedCrossRef
49.
Nagy L, Szanto A, Szatmari I, Széles L (2012) Nuclear hormone receptors enable macrophages and dendritic cells to sense their lipid environment and shape their immune response. Physiol Rev 92:739–789PubMedCrossRef
50.
51.
Gombart AF, Borregaard N, Koeffler HP (2005) Human cathelicidin antimicrobial peptide (CAMP) is a direct target of the vitamin D receptor and is strongly upregulated in myeloid cells by 1,25-dihydroxyvitamin D3. FASEB J 19:1067–1077PubMedCrossRef
52.
Weber G, Heilborn JD, Chamorro Jimenez CI, Hammarsjo A, Törmä H, Stahle M (2005) Vitamin D induces the antimicrobial protein hCAP18 in human skin. J Invest Dermatol 124:1080–1082PubMedCrossRef
53.
Fabri M, Stenger S, Shin DM, Yuk JM, Liu PT, Realegeno S, Lee HM, Krutzik SR, Schenk M, Sieling PA, Teles R, Montoya D, Iyer SS, Bruns H, Lewinsohn DM, Hollis BW, Hewison M, Adams JS, Steinmeyer A, Zügel U, Cheng G, Jo EK, Bloom BR, Modlin RL (2011) Vitamin D is required for IFN-γ-mediated antimicrobial activity of human macrophages. Sci Trans Med 3:104ra102CrossRef
54.
Edfeldt K, Liu PT, Chun R, Fabri M, Schenk M, Wheelwright M, Keegan C, Krutzik SR, Adams JS, Hewison M, Modlin RL (2010) T-cell cytokines differentially control human monocyte antimicrobial responses by regulating vitamin D metabolism. Proc Natl Acad Sci USA 107:22593–22598PubMedCrossRef
55.
Battersby AJ, Kampmann B, Burl S (2012) Vitamin D in early childhood and the effect on immunity to Mycobacterium tuberculosis. Clin Dev Immunol 2012:430972PubMedCrossRef
56.
Sadeghi K, Wessner B, Laggner U et al (2006) 1,25(OH)2D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns. Eur J Immunol 36:361–370PubMedCrossRef
57.
van Driel M, Koedam M, Buurman CJ, Hewison M, Chiba H, Uitterlinden AG, Pols HA, van Leeuwen JP (2006) Evidence for auto/paracrine actions of vitamin D in bone: 1 alpha hydroxylase expression and activity in human bone cells. FASEB J 13:2417–2419CrossRef
58.
Hewison M, Freeman L, Hughes SV et al (2003) Dufferential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells. J Immunol 170:5382–5390PubMed
59.
Alroy I, Towers T, Freedman LP (1995) Transcriptional repression of interleukin-2 gene by 1,25(OH)2D3: direct inhibition NFATp/AP-1 complex formation by a nuclear hormone receptor. Mol Cell Biol 15:5789–5799PubMed
60.
Mahon BD, Wittke A, Weaver V, Cantorna MT (2003) The targets of vitamin D depend on the differentiation and activation status of CD4-positive T-cells. J Cell Biochem 89:922–932PubMedCrossRef
61.
Bansal ASHF, Sumar N, Patel S (2012) T helper cell subsets in arthritis and the benefits of immunomodulation by 1,25(OH)2 vitamin D. Rheumatol Int 32:845–852PubMedCrossRef
62.
Ooi JH, Chen J, Cantorna MT (2012) Vitamin D regulation of immune function in the gut: why do T cells have vitamin D receptors? Mol Aspects Med 33:77–82PubMedCrossRef
63.
Kamen DL, Wu S, Rhee KJ, Albesiano E et al (2009) A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med 15:1016–1022CrossRef
64.
Kamen DL, Tangpricha V (2010) Vitamin D and molecular actions on the immune system: modulation of innate and autoimmunity. J Mol Med 88:441–450PubMedCrossRef
65.
Adams JS, Gacad MA (1985) Characterization of 1 alpha-hydroxylation of 1,25(OH)2D3 sterol by cultured alveolar macrophages from patients with sarcoidosis. J Exp Med 161:755–765PubMedCrossRef
66.
Vernino L, McAnally LM, Ramberg J, Lipsky PE (1992) Generation of nondividing high-rate Ig-secreting plasma-cells in cultures of human B-cells stimulated with anti-Cd3-acti- vated T-cells. J Immunol 148:404–410PubMed
67.
Grammer AC, Lipsky PE (2003) B cell abnormalities in systemic lupus erythematosus. Arthritis Res Ther 5:S22–S27PubMedCrossRef
68.
Heine G, Niesner U, Chang HD, Steinmeyer A, Zügel U, Zuberbier T, Radbruch A, Worm M (2008) 1,25-dihydroxyvitamin D(3) promotes IL-10 production in human B cells. Eur J Immunol 38:2210–2218PubMedCrossRef
69.
Shirakawa AK, Nagakubo D, Hieshima K, Nakayama T, Jin Z, Yoshie O (2008) 1,25-dihydroxyvitamin D3 induces CCR10 expression in terminally differentiating human B cells. J Immunol 180:2786–2795PubMed
70.
Jones AP, Tulic MK, Rueter K, Prescott SL (2012) Vitamin D and allergic disease: sunlight at the end of the tunnel? Nutrients 4:13–28PubMedCrossRef
71.
Chun RFAJ, Hewison M (2011) Immunomodulation by vitamin D: implications for TB. Expert Rev Clin Pharmacol 4:583–591PubMedCrossRef
72.
Yim S, Dhawan P, Ragunath C, Christakos S, Diamond G (2007) Induction of cathelicidin in normal and CF bronchial epithelial cells by 1,25-dihydroxyvitamin D3. J Cyst Fibros 6:403–410PubMedCrossRef
73.
Wu S, Liao AP, Xia Y, Li YC, Li JD, Sartor RB, Sun J (2010) Vitamin D receptor negatively regulates bacterial-stimulated NF-kappaB activity in intestine. Am J Pathol 177:686–697PubMedCrossRef
74.
Wehkamp J, Schauber J, Stange EF (2007) Defensins and cathelicidins in gastrointestinal infections. Curr Opin Gastroenterol 23:32–38PubMedCrossRef
75.
Ginde AA, Mansbach JM, Camargo CA Jr (2009) Association between serum 25-hydroxyvitamin D and upper respiratory tract infection in the third national Health and Nutrition Examination survey. Arch Intern Med 169:384–390PubMedCrossRef
76.
von Essen MR, Kongsbak M, Schjerling P, Olgaard K, Odum N, Geisler C (2010) Vitamin D controls T cell antigen receptor signaling and activation of human T cells. Nat Immunol 11:344–349CrossRef
77.
Grant WB (2008) Variation in Vitamin D production could possibly explain the seasonality of childhood respiratory infection in Hawaii. Pediatr Infect Dis J 27:853PubMed
78.
Rodríguez M, Daniels B, Gunawardene S, Robbins GK (2009) High frequency of vitamin D deficiency in ambulatory HIV-positive patients. AIDS Res Hum Retroviruses 25:9–14PubMedCrossRef
79.
Abu-Mouch S, Fireman Z, Jarchovsky J, Zeina AR, Assy N (2011) Vitamin D supplementation improves sustained virologic response in chronic hepatitis C (genotype 1)-naïve patients. World J Gastroenterol 17:5184–5190PubMedCrossRef
80.
Nimer A, Mouch A (2012) Vitamin D improves viral response in hepatitis C genotype 2–3 naïve patients. World J Gastroenterol 18:800–805PubMedCrossRef
81.
Zitt E, Sprenger-Mähr H, Knoll F, Neyer U, Lhotta K (2012) Vitamin D deficiency is associated with poor response to active hepatitis B immunisation in patients with chronic kidney disease. Vaccine 30:931–935PubMedCrossRef
82.
Ovsyannikova IG, Haralambieva IH, Vierkant RA, O’Byrne MM, Jacobson RM, Poland GA (2012) Effects of vitamin A and D receptor gene polymorphisms/haplotypes on immune responses to measles vaccine. Pharmacogenet Genomics 22:20–31PubMedCrossRef
83.
Ovsyannikova IG, Dhiman N, Haralambieva IH, Vierkant RA, O’Byrne MM, Jacobson RM, Poland GA (2010) Rubella vaccine-induced cellular immunity: evidence of associations with polymorphisms in the Toll-like, vitamin A and D receptors, and innate immune response genes. Hum Genet 127:207–221PubMedCrossRef
84.
Lalor MK, Floyd S, Gorak-Stolinska P, Weir RE, Blitz R, Branson K, Fine PE, Dockrell HM (2011) BCG vaccination: a role for vitamin D? PLoS One 6:e16709PubMedCrossRef
85.
Bruce D, Ooi JH, Yu S, Cantorna MT (2010) Vitamin D and host resistance to infection? Putting the cart in front of the horse. Exp Biol Med (Maywood) 235:921–927CrossRef
86.
Helming L, Böse J, Ehrchen J, Schiebe S, Frahm T, Geffers R, Probst-Kepper M, Balling R, Lengeling A (2005) 1alpha,25-dihydroxyvitamin D3 is a potent suppressor of interferon gamma-mediated macrophage activation. Blood 106:4351–4358PubMedCrossRef
87.
Bruce D, Whitcomb JP, August A, McDowell MA, Cantorna MT (2009) Elevated non-specific immunity and normal Listeria clearance in young and old vitamin D receptor knockout mice. Int Immunol 21:113–122PubMedCrossRef
88.
Ehrchen J, Helming L, Varga G, Pasche B, Loser K, Gunzer M, Sunderkötter C, Sorg C, Roth J, Lengeling A (2007) Vitamin D receptor signaling contributes to susceptibility to infection with Leishmania major. FASEB J 21(12):3208–3218PubMedCrossRef
89.
Waters WR, Palmer MV, Nonnecke BJ, Whipple DL, Horst RL (2004) Mycobacterium bovis infection of vitamin D-deficient NOS2−/− mice. Microb Pathog 36:11–17PubMedCrossRef
90.
Cantorna MT, Hullett DA, Redaelli C, Brandt CR, Humpal-Winter J, Sollinger HW, Deluca HF (1998) 1,25-dihydroxyvitamin D3 prolongs graft survival without compromising host resistance to infection or bone mineral density. Transplantation 66:828–831PubMedCrossRef
91.
Froicu M, Weaver V, Wynn TA, McDowell MA, Welsh JE, Cantorna MT (2003) A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases. Mol Endocrinol 17:2386–2392PubMedCrossRef
92.
Gombart AF (2009) The vitamin D-antimicrobial peptide pathway and its role in protection against infection. Future Microbiol 4:1151–1165PubMedCrossRef
93.
Lagishetty V, Liu NQ, Hewison M (2011) Vitamin D metabolism and innate immunity. Mol Cell Endocrinol 347:97–105PubMedCrossRef
94.
Rook GA, Steele J, Fraher L, Barker S, Karmali R, O’Riordan J, Stanford J (1986) Vitamin D3, gamma interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes. Immunology 57:159–163PubMed
95.
Wang TT, Nestel FP, Bourdeau V et al (2004) Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol 173:2909–2912PubMed
96.
Adams JS, Ren S, Liu PT, Chun RF, Lagishetty V, Gombart AF, Borregaard N, Modlin RL, Hewison M (2009) Vitamin D-directed rheostatic regulation of monocyte antibacterial responses. J Immunol 182:4289–4295PubMedCrossRef
97.
Montoya D, Cruz D, Teles RM, Lee DJ, Ochoa MT, Krutzik SR, Chun R, Schenk M, Zhang X, Ferguson BG, Burdick AE, Sarno EN, Rea TH, Hewison M, Adams JS, Cheng G, Modlin RL (2009) Divergence of macrophage phagocytic and antimicrobial programs in leprosy. Cell Host Microbe 6:343–353PubMedCrossRef
98.
Bergman P, Walter-Jallow L, Broliden K, Agerberth B, Söderlund J (2007) The antimicrobial peptide LL-37 inhibits HIV-1 replication. Curr HIV Res 5:410–415PubMedCrossRef
99.
Leikina E, Delanoe-Ayari H, Melikov K, Cho MS, Chen A, Waring AJ, Wang W, Xie Y, Loo JA, Lehrer RI, Chernomordik LV (2005) Carbohydrate-binding molecules inhibit viral fusion and entry by crosslinking membrane glycoproteins. Nat Immunol 6:995–1001PubMedCrossRef
100.
Schauber J, Dorschner RA, Coda AB, Büchau AS, Liu PT, Kiken D, Helfrich YR, Kang S, Elalieh HZ, Steinmeyer A, Zügel U, Bikle DD, Modlin RL, Gallo RL (2007) Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. J Clin Invest 117:803–811PubMedCrossRef
101.
Liu N, Nguyen L, Chun RF, Lagishetty V, Ren S, Wu S, Hollis B, DeLuca HF, Adams JS, Hewison M (2008) Altered endocrine and autocrine metabolism of vitamin D in a mouse model of gastrointestinal inflammation. Endocrinology 149:4799–4808PubMedCrossRef
102.
Yuk JM, Shin DM, Lee HM, Yang CS, Jin HS, Kim KK, Lee ZW, Lee SH, Kim JM, Jo EK (2009) Vitamin D3 induces autophagy in human monocytes/macrophages via cathelicidin. Cell Host Microbe 6:231–243PubMedCrossRef
103.
Evans KN, Nguyen L, Chan J, Innes BA, Bulmer JN, Kilby MD, Hewison M (2006) Effects of 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 on cytokine production by human decidual cells. Biol Reprod 75:816–822PubMedCrossRef
104.
Liu N, Kaplan AT, Low J, Nguyen L, Liu GY, Equils O, Hewison M (2009) Vitamin D induces innate antibacterial responses in human trophoblasts via an intracrine pathway. Biol Reprod 80:398–406PubMedCrossRef
105.
Lagishetty V, Misharin AV, Liu NQ, Lisse TS, Chun RF, Ouyang Y, McLachlan SM, Adams JS, Hewison M (2010) Vitamin D deficiency in mice impairs colonic antibacterial activity and predisposes to colitis. Endocrinology 151:2423–2432PubMedCrossRef
106.
D’Aldebert E, Biyeyeme Bi Mve MJ, Mergey M, Wendum D, Firrincieli D, Coilly A, Fouassier L, Corpechot C, Poupon R, Housset C, Chignard N (2009) Bile salts control the antimicrobial peptide cathelicidin through nuclear receptors in the human biliary epithelium. Gastroenterology 136:1435–1445PubMedCrossRef
107.
Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo-Arvizu RA, Gallagher JC, Gallo RL, Jones G, Kovacs CS, Mayne ST, Rosen CJ, Shapses SA (2011) The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 96:53–58PubMedCrossRef
108.
Slomski A (2011) IOM endorses vitamin D, calcium only for bone health, dispels deficiency claims. JAMA 305(453–454):456
109.
Reid IR, Avenell A (2011) Evidence-based policy on dietary calcium and vitamin D. J Bone Miner Res 26:452–454PubMedCrossRef
110.
Hollis BW (2011) Short-term and long-term consequences and concerns regarding valid assessment of vitamin D deficiency: comparison of recent food supplementation and clinical guidance reports. Curr Opin Clin Nutr Metab Care 14:598–604PubMedCrossRef
111.
Heaney RP, Holick MF (2011) Why the IOM recommendations for vitamin D are deficient. J Bone Miner Res 26:455–457PubMedCrossRef
112.
Grant WB (2011) The Institute of Medicine did not find the vitamin D-cancer link because it ignored UV-B dose studies. Public Health Nutr 14:745–746PubMedCrossRef
113.
Grant WB, Boucher BJ (2011) Requirements for vitamin D across the life span. Biol Res Nurs 13:120–133PubMedCrossRef
114.
Hollis BW, Wagner CL (2011) The vitamin D requirement during human lactation: the facts and IOM’s ‘utter’ failure. Public Health Nutr 14:748–749PubMedCrossRef
115.
Dawson-Hughes B, Mithal A, Bonjour JP, Boonen S, Burckhardt P, Fuleihan GE, Josse RG, Lips P, Morales-Torres J, Yoshimura N (2010) IOF position statement: vitamin D recommendations for older adults. Osteoporos Int 21:1151–1154PubMedCrossRef
116.
117.
Herr C, Greulich T, Koczulla RA, Meyer S, Zakharkina T, Brandscheidt M, Eschmann R, Bals R (2011) The role of vitamin D in pulmonary disease: COPD, astham, infection, and cancer. Respir Res 12:31PubMedCrossRef
118.
Brehm JM, Schuemann B, Fuhlbrigge AL, Hollis BW, Strunk RC, Zeiger RS, Weiss ST, Litonjua AA, Childhood Asthma Management Program Research Group (2010) Serum vitamin D levels and severe asthma exacerbations in the Childhood Asthma Management Program study. J Allergy Clin Immunol 126:52.e55–58.e55CrossRef
119.
Kunisaki KM, Niewoehner DE, Connett JE, COPD Clinical Research Network (2012) Vitamin D levels and risk of acute exacerbations of chronic obstructive pulmonary disease: a prospective cohort study. Am J Respir Crit Care Med 185:286–290PubMedCrossRef
120.
Diamond G, Legarda D, Ryan LK (2000) The innate immune response of the respiratory epithelium. Immunol Rev 173:27–38PubMedCrossRef
121.
Nnoaham KE, Clarke A (2008) Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis. Int J Epidemiol 37:113–119PubMedCrossRef
122.
Pfleiderer M, Löwer J, Kurth R (2001) Cold-attenuated live influenza vaccines, a risk-benefit assessment. Vaccine 20:886–894PubMedCrossRef
123.
Cannell JJ, Vieth R, Umhau JC, Holick MF, Grant WB, Madronich S, Garland CF, Giovannucci E (2006) Epidemic influenza and vitamin D. Epidemiol Infect 134:1129–1140PubMedCrossRef
124.
Haug CJ, Müller F, Rollag H, Aukrust P, Degré M, Frøland SS (1996) The effect of 1,25-vitamin D3 on maturation of monocytes from HIV-infected patients varies with degree of immunodeficiency. APMIS 104:539–548PubMedCrossRef
125.
Mehta S, Mugusi FM, Spiegelman D, Villamor E, Finkelstein JL, Hertzmark E, Giovannucci EL, Msamanga GI, Fawzi WW (2011) Vitamin D status and its association with morbidity including wasting and opportunistic illnesses in HIV-infected women in Tanzania. AIDS Patient Care STDS 25:579–585PubMedCrossRef
126.
Terrier B, Carrat F, Geri G, Pol S, Piroth L, Halfon P, Poynard T, Souberbielle JC, Cacoub P (2011) Low 25-OH vitamin D serum levels correlate with severe fibrosis in HIV-HCV co-infected patients with chronic hepatitis. J Hepatol 55:756–761PubMedCrossRef
127.
Van Den Bout-Van Den Beukel CJ, Fievez L, Michels M, Sweep FC, Hermus AR, Bosch ME, Burger DM, Bravenboer B, Koopmans PP, Van Der Ven AJ (2008) Vitamin D deficiency among HIV type 1-infected individuals in the Netherlands: effects of antiretroviral therapy. AIDS Res Hum Retroviruses 24:1375–1378CrossRef
128.
Connor RI, Rigby WF (1991) 1 alpha,25-dihydroxyvitamin D3 inhibits productive infection of human monocytes by HIV-1. Biochem Biophys Res Commun 176:852–859PubMedCrossRef
129.
Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B (2006) Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 84:18–28PubMed
130.
Arai H, Miyamoto K, Taketani Y, Yamamoto H, Iemori Y, Morita K, Tonai T, Nishisho T, Mori S, Takeda E (1997) A vitamin D receptor gene polymorphism in the translation initiation codon: effect on protein activity and relation to bone mineral density in Japanese women. J Bone Miner Res 12:915–921PubMedCrossRef
131.
Janssen R, Bont L, Siezen CL, Hodemaekers HM, Ermers MJ, Doornbos G, van’t Slot R, Wijmenga C, Goeman JJ, Kimpen JL, van Houwelingen HC, Kimman TG, Hoebee B (2007) Genetic susceptibility to respiratory syncytial virus bronchiolitis is predominantly associated with innate immune genes. J Infect Dis 196:826–834PubMedCrossRef
132.
Gao L, Tao Y, Zhang L, Jin Q (2010) Vitamin D receptor genetic polymorphisms and tuberculosis: updated systematic review and meta-analysis. Int J Tuberc Lung Dis 14:15–23PubMed
133.
Zhang HQ, Deng A, Guo CF, Wang YX, Chen LQ, Wang YF, Wu JH, Liu JY (2010) Association between FokI polymorphism in vitamin D receptor gene and susceptibility to spinal tuberculosis in Chinese Han population. Arch Med Res 41:46–49PubMedCrossRef
134.
Lemire JM (1995) Immunomodulatory actions of 1,25-dihydroxy1,25(OH)2D3. J Steroid Biochem Mol Biol 53:599–602PubMedCrossRef
135.
Søborg C, Andersen AB, Range N, Malenganisho W, Friis H, Magnussen P, Temu MM, Changalucha J, Madsen HO, Garred P (2007) Influence of candidate susceptibility genes on tuberculosis in a high endemic region. Mol Immunol 44:2213–2220PubMedCrossRef
136.
Lewis SJ, Baker I, Davey Smith G (2005) Meta-analysis of vitamin D receptor polymorphisms and pulmonary tuberculosis risk. Int J Tuberc Lung Dis 9:1174–1177PubMed
137.
Martineau AR, Timms PM, Bothamley GH, Hanifa Y, Islam K, Claxton AP, Packe GE, Moore-Gillon JC, Darmalingam M, Davidson RN, Milburn HJ, Baker LV, Barker RD, Woodward NJ, Venton TR, Barnes KE, Mullett CJ, Coussens AK, Rutterford CM, Mein CA, Davies GR, Wilkinson RJ, Nikolayevskyy V, Drobniewski FA, Eldridge SM, Griffiths CJ (2011) High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial. Lancet 377:242–250PubMedCrossRef
138.
Arnaud J, Constans J (1993) Affinity differences for vitamin D metabolites associated with the genetic isoforms of the human serum carrier protein (DBP). Hum Genet 92:183–188PubMedCrossRef
139.
Chun RF, Lauridsen AL, Suon L, Zella LA, Pike JW, Modlin RL, Martineau AR, Wilkinson RJ, Adams J, Hewison M (2010) Vitamin D-binding protein directs monocyte responses to 25-hydroxy- and 1,25-dihydroxyvitamin D. J Clin Endocrinol Metab 95:3368–3376PubMedCrossRef
140.
Martineau AR, Leandro AC, Anderson ST, Newton SM, Wilkinson KA, Nicol MP, Pienaar SM, Skolimowska KH, Rocha MA, Rolla VC, Levin M, Davidson RN, Bremner SA, Griffiths CJ, Eley BS, Bonecini-Almeida MG, Wilkinson RJ (2009) Association between Gc genotype and susceptibility to TB is dependent on vitamin D status. Eur Respir J 35:1106–1112PubMedCrossRef
141.
Wejse C, Gomes VF, Rabna P, Gustafson P, Aaby P, Lisse IM, Andersen PL, Glerup H, Sodemann M (2009) Vitamin D as supplementary treatment for tuberculosis: a double-blind, randomized, placebo-controlled trial. Am J Respir Crit Care Med 179:843–850PubMedCrossRef
142.
Martineau AR, Wilkinson RJ, Wilkinson KA, Newton SM, Kampmann B, Hall BM, Packe GE, Davidson RN, Eldridge SM, Maunsell ZJ, Rainbow SJ, Berry JL, Griffiths CJ (2007) A single dose of vitamin D enhances immunity to mycobacteria. Am J Respir Crit Care Med 176:208–213PubMedCrossRef
143.
Nursyam EW, Amin Z, Rumende CM (2006) The effect of vitamin D as supplementary treatment in patients with moderately advanced pulmonary tuberculous lesion. Acta Med Indones 38:3–5PubMed
144.
Morcos MM, Gabr AA, Samuel S, Kamel M, Baz M el, Beshry M el, Michail RR (1998) Vitamin D administration to tuberculous children and its value. Boll Chim Farm 137:157–164PubMed
145.
Manaseki-Holland S, Maroof Z, Bruce J, Mughal MZ, Masher MI, Bhutta ZA, Walraven G, Chandramohan D (2012) Effect on the incidence of pneumonia of vitamin D supplementation by quarterly bolus dose to infants in Kabul: a randomised controlled superiority trial. Lancet 379:1419–1427PubMedCrossRef
146.
Kawaura A (2006) Inhibitory effect of long term 1alpha-hydroxyvitamin D3 administration on Helicobacter pylori infection. J Clin Biochem Nutr 38:103–106CrossRef
147.
148.
Aloia JF, Li-Ng M (2007) Re: epidemic influenza and vitamin D [with author reply]. Epidemiol Infect 135:1095–1096PubMedCrossRef
149.
Avenell A, Cook JA, Maclennan GS, Macpherson GC (2007) Vitamin D supplementation to prevent infections: a sub-study of a randomised placebo-controlled trial in older people (RECORD trial, ISRCTN 51647438). Age Ageing 36:574–577PubMedCrossRef
150.
Li-Ng M, Aloia JF, Pollack S, Cunha BA, Mikhail M, Yeh J, Berbari N (2009) A randomized controlled trial of vitamin D3 supplementation for the prevention of symptomatic upper respiratory tract infections. Epidemiol Infect 137:1396–1404PubMedCrossRef
151.
Urashima M, Segawa T, Okazaki M, Wada Y, Ida H (2010) Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am J Clin Nutr 91:1255–1260PubMedCrossRef
152.
Laaksi I, Ruohola JP, Mattila V, Auvinen A, Ylikomi T, Pihlajamäki H (2010) Vitamin D supplementation for the prevention of acute respiratory tract infection: a randomized, double-blinded trial among young Finnish men. J Infect Dis 202:809–814PubMedCrossRef
153.
Arpadi SM, McMahon D, Abrams EJ, Bamji M, Purswani M, Engelson ES, Horlick M, Shane E (2009) Effect of bimonthly supplementation with oral cholecalciferol on serum 25-hydroxyvitamin D concentrations in HIV-infected children and adolescents. Pediatrics 123:e121–e126, Erratum in: Pediatrics. 2009 May;2123(2005):1437PubMedCrossRef
154.
Kakalia S, Sochett EB, Stephens D, Assor E, Read SE, Bitnun A (2011) Vitamin D supplementation and CD4 count in children infected with human immunodeficiency virus. J Pediatr 159:951–957PubMedCrossRef
155.
Snyman JR, de Sommers K, Steinmann MA, Lizamore DJ (1997) Effects of calcitriol on eosinophil activity and antibody responses in patients with schistosomiasis. Eur J Clin Pharmacol 52:277–280PubMedCrossRef
156.
Moe SM, Zekonis M, Harezlak J, Ambrosius WT, Gassensmith CM, Murphy CL, Russell RR, Batiuk TD (2001) A placebo-controlled trial to evaluate immunomodulatory effects of paricalcitol. Am J Kidney Dis 38:792–802PubMedCrossRef
157.
Kriesel JDSJ (1999) Calcitriol (1,25-dihydroxy-vitamin D3) coadministered with influenza vaccine does not enhance humoral immunity in human volunteers. Vaccine 17:1883–1888PubMedCrossRef
158.
Martineau AR, Honecker FU, Wilkinson RJ, Griffiths CJ (2012) Bolus-dose vitamin D and prevention of childhood pneumonia. Lancet 379:1373–1375PubMedCrossRef
159.
Yusupov E, Li-Ng M, Pollack S, Yeh JK, Mikhail M, Aloia JF (2010) Vitamin D and serum cytokines in a randomized clinical trial. Int J Endocrinol. Doi:10.​1155/​2010/​305054
160.
Rodriguez-Torres M, Jeffers LJ, Sheik MY, Rossaro L, Ankoma-Sey V, Hamzeh FM, Martin P, Latino Study Group (2009) Peginterferon alfa-2a and Ribavirin in Latino and non-Latino whites with hepatitis C. N Eng J Med 360:257–267CrossRef
161.
Ge D, Fellay J, Thompson AJ, Simon JS, Shianna KV, Urban TJ, Heinzen EL, Qiu P, Bertelsen AH, Muir AJ, Sulkowski M, McHutchison JG, Goldstein DB (2009) Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 461:399–401PubMedCrossRef
162.
Loguercio C, Frederico A, Massarone M, Torella R, Blanco Cdel V, Persico M (2008) The impact of diet on liver fibrosis and on response to interferon therapy in patients with HCV-related chronic hepatatis. Am J Gastroenterol 103:3159–3166PubMedCrossRef
163.
Daynes RA, Enioutina EY, Butler S, Mu HH, McGee ZA, Araneo BA (1996) Induction of common mucosal immunity by hormonally immunomodulated peripheral immunization. Infect Immun 64:1100–1109PubMed
164.
Enioutina EY, Bareyan D, Daynes RA (2008) TLR ligands that stimulate the metabolism of vitamin D3 in activated murine dendritic cells can function as effective mucosal adjuvants to subcutaneously administered vaccines. Vaccine 26:601–613PubMedCrossRef
165.
Enioutina EY, Bareyan D, Daynes RA (2009) TLR-induced local metabolism of vitamin D3 plays an important role in the diversification of adaptive immune responses. J Immunol 182:4296–4305PubMedCrossRef
166.
Chadha MK, Fakih M, Muindi J, Tian L, Mashtare T, Johnson CS, Trump D (2011) Effect of 25-hydroxyvitamin D status on serological response to influenza vaccine in prostate cancer patients. Prostate 71:368–372PubMedCrossRef
167.
Daynes RA, Araneo BA, Hennebold J, Enioutina E, Mu HH (1995) Steroids as regulators of the mammalian immune response. J Invest Dermatol 105(1 Suppl):14S–19SPubMedCrossRef
168.
Daynes RA, Araneo BA (1994) The development of effective vaccine adjuvants employing natural regulators of T-cell lymphokine production in vivo. Ann NY Acad Sci 730:144–161PubMedCrossRef
169.
Lang PO, Govind S, Mitchell WA, Siegrist CA, Aspinall R (2011) Vaccine effectiveness in older individuals: what has been learned from the influenza-vaccine experience. Ageing Res Rev 10:389–395PubMedCrossRef
170.
Cooper C, Thorne A, Canadian HIV Trials Network Ctn Influenza Vaccine Research Group (2011) Vitamin D supplementation does not increase immunogenicity of seasonal influenza vaccine in HIV-infected adults. HIV Clin Trials 12:275–276PubMedCrossRef
Metadaten
Titel
How important is vitamin D in preventing infections?
verfasst von
P. O. Lang
N. Samaras
D. Samaras
R. Aspinall
Publikationsdatum
01.05.2013
Verlag
Springer-Verlag
Erschienen in
Osteoporosis International / Ausgabe 5/2013
Print ISSN: 0937-941X
Elektronische ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-012-2204-6

Weitere Artikel der Ausgabe 5/2013

Osteoporosis International 5/2013 Zur Ausgabe

Original Article

Drug rash with eosinophilia and systemic symptoms (DRESS) in patients receiving strontium ranelate

Review

PTH replacement therapy of hypoparathyroidism

Original Article

Peripheral arterial disease increases the risk of subsequent hip fracture in older men: the Health in Men Study

Original Article

Alterations of bone microstructure and strength in end-stage renal failure

Opinion Paper

Vitamin D: do we get enough?

Letter

Vitamin D and atypical femoral fractures

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Neu im Fachgebiet Orthopädie und Unfallchirurgie

Knie-TEP: Kein Vorteil durch antibiotikahaltigen Knochenzement

29.05.2024 Periprothetische Infektionen Nachrichten

Zur Zementierung einer Knie-TEP wird in Deutschland zu über 98% Knochenzement verwendet, der mit einem Antibiotikum beladen ist. Ob er wirklich besser ist als Zement ohne Antibiotikum, kann laut Registerdaten bezweifelt werden.

Häusliche Gewalt in der orthopädischen Notaufnahme oft nicht erkannt

28.05.2024 Häusliche Gewalt Nachrichten

In der Notaufnahme wird die Chance, Opfer von häuslicher Gewalt zu identifizieren, von Orthopäden und Orthopädinnen offenbar zu wenig genutzt. Darauf deuten die Ergebnisse einer Fragebogenstudie an der Sahlgrenska-Universität in Schweden hin.

Fehlerkultur in der Medizin – Offenheit zählt!

28.05.2024 Fehlerkultur Podcast

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Mehr Frauen im OP – weniger postoperative Komplikationen

21.05.2024 Allgemeine Chirurgie Nachrichten

Ein Frauenanteil von mindestens einem Drittel im ärztlichen Op.-Team war in einer großen retrospektiven Studie aus Kanada mit einer signifikanten Reduktion der postoperativen Morbidität assoziiert.

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise